Summary
For Year 2026-27, Aarey Drugs & Pharmaceuticals reports the following shareholding: Total Promoters at 37.71%, Mutual Fund at 0%, Insurance at 0%, Foreign Institutional Investors at 4.18%, Domestic Institutional Investors at 0%, and Retail at 58.11%. This breakdown provides a quick snapshot of ownership distribution for Aarey Drugs & Pharmaceuticals in 2026-27.
Aarey Drugs & Pharmaceuticals FAQs
As of 04-2026, the promoter shareholding in Aarey Drugs & Pharmaceuticals stands at 37.71% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of Aarey Drugs & Pharmaceuticals is 4.18% and 0% respectively.
The retail shareholding of the Aarey Drugs & Pharmaceuticals is 58.11%.
Changes in shareholding patterns of Aarey Drugs & Pharmaceuticals can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of Aarey Drugs & Pharmaceuticals are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
Aarey Drugs & Pharmaceuticals Associated Pages
- Aarey Drugs & Pharmaceuticals Share Price
- Aarey Drugs & Pharmaceuticals Share Price chart
- Aarey Drugs & Pharmaceuticals Fundamental Analysis
- Aarey Drugs & Pharmaceuticals Technical Analysis
- Aarey Drugs & Pharmaceuticals Peer Comparison
- Aarey Drugs & Pharmaceuticals Share Price History
- Aarey Drugs & Pharmaceuticals Board of Directors
